News

All

November 14, 2022

Brazilian Data Protection Authority publishes its 2023-2024 Regulatory Agenda

On November 8, 2022, the Brazilian Data Protection Authority (“Authority”) published its 2023-2024 Regulatory Agenda (“Current Agenda”), establishing high-priority topics over the Brazilian Data Protection Authority publishes its 2023-2024 Regulatory Agenda

Ler notícia

November 10, 2022

Bill creates Legal Framework for the Electronic Games Industry in Brazil

On October 19, 2022, the Brazilian House of Representatives approved Bill No. 2.796/2021 that creates a legal framework for the Brazilian gaming Bill creates Legal Framework for the Electronic Games Industry in Brazil

Ler notícia

November 9, 2022

Brazil: Patent Litigation 2023 – IAM Media

Our partner Claudio Barbosa and our Attorney at Law Viviane Trojan are the authors of the article “Brazil: Patent Litigation”, published in the Global Patent Brazil: Patent Litigation 2023 – IAM Media

Ler notícia

October 20, 2022

CFM updates its Resolution on cannabidiol prescription and use

The Federal Council of Medicine (CFM) published, on 10/14/2022, CFM Resolution No. 2,324/22, which authorizes the use of cannabidiol (CBD) for treatment CFM updates its Resolution on cannabidiol prescription and use

Ler notícia

October 14, 2022

Copyright registration in Brazil may now be submitted via online system

While registration is not mandatory in Brazil for copyright protection, it is a recommended measure as it may serve as evidence of Copyright registration in Brazil may now be submitted via online system

Ler notícia

September 30, 2022

Brazilian Patent Office (BPO) announces that the limit of PPH requests for 2022 has been reached

The Brazilian Patent Office (BPO) announced on September 29, 2022, that the limit of PPH (Patent Prosecution Highway) requests for the year Brazilian Patent Office (BPO) announces that the limit of PPH requests for 2022 has been reached

Ler notícia

September 28, 2022

ANVISA approves new Resolution RDC related to Medical Devices

ANVISA published, in the Federal Official Gazette, RDC No. 751/2022, which provides and defines, in relation to medical devices, the (i) risk classification rules; (ii) labeling ANVISA approves new Resolution RDC related to Medical Devices

Ler notícia

August 16, 2022

Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

On August 8th, 2022, during the 12th Extraordinary Public Meeting of DICOL, ANVISA’s Collegiate Board of Directors announced the completion of the toxicological Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

Ler notícia

August 15, 2022

Protecting Plant Varieties in Brazil for FloraCulture Magazine

Our partner and head of Life Sciences, Priscila Kashiwabara discusses plant variety protection in Brazil and its recent developments regarding legal framework for Plant Protecting Plant Varieties in Brazil for FloraCulture Magazine

Ler notícia

July 19, 2022

Carbendazim toxicological revaluation about to be completed by ANVISA

In December 2019, ANVISA started the process of toxicological revaluation of the Active Ingredient (AI) Carbendazim, as signs of toxicity were identified Carbendazim toxicological revaluation about to be completed by ANVISA

Ler notícia

July 6, 2022

Compulsory license: patent owners in Brazil are under no obligation to provide know-how and raw materials

Good news for patent owners in Brazil: the National Congress has upheld the President’s veto n° 48/2021, which prevented those who had their Compulsory license: patent owners in Brazil are under no obligation to provide know-how and raw materials

  • Kasznar Leonardos
  • Ler notícia

    June 21, 2022

    Provisional Measure Transforms the Brazilian Data Protection Authority into an Independent Entity

    Provisional Measure 1,124/22 published this past June 14, 2022, transformed the Brazilian Data Protection Authority into a special nature entity. The Measure is Provisional Measure Transforms the Brazilian Data Protection Authority into an Independent Entity

    Ler notícia